Huadong Medicine targets infringement of "Suyan Zhen"! What's the deal with the confrontation of the two "Girl Needle" from a distance?

① “Yi Yanshi”, a subsidiary of Huadong Pharmaceutical, claims that Cai Cai Medical's “Su Yan Zhen” infringes on its invention patent rights and has now filed a civil lawsuit; ② Gu Yuchun, the parent company of Cai Cai Medical, has denied this claim. Up to now, “Su Yan Zhen” has been on the market for less than two months; ③ Industry insiders believe that it is now difficult to define whether Gu Yuchun is infringing.

cls.cnOct 12 08:24 ET

Wanbangde Pharmaceutical Holding Group: The financial director, who served for only eight months, resigned, and the chairman once again acted as the director. | Quick Read Announcement

①Tonight, wanbangde pharmaceutical holding group announced that the Chief Financial Officer Wang Tianfang has resigned, having served in this position for only 8 months; ②Chairman Zhao Shouming once again assumes the responsibilities of the Chief Financial Officer, having temporarily served in this role when the former CFO Zhao Junhui resigned in June 2022; ③Within three years, wanbangde pharmaceutical holding group's market cap has shrunk to only one-third.

cls.cnSep 29 11:29 ET

4 million! Star Chain users reach a new milestone, expected to achieve positive free cash flow for the first time.

①Institutions expect that Starlink's revenue will likely increase by 80% year-on-year, and will achieve positive free cash flow for the first time; ②Global satellite operators are actively deploying low-orbit communication constellations, with commercial prospects and scarce orbital resources being the main driving force accelerating the layout.

cls.cnSep 27 04:30 ET

"Miracle drug" for reducing fever – An Gong Niu Huang Wan and Zhangzhou Pientzehuang Pharmaceutical are being recalled in many places, causing a decline in market prices | Industry News

①The price of Angong Niuhuang Pills and Zinc Ingot of Zhangzhou Pientzehuang Pharmaceuticals has dropped, with a decrease of more than 100 yuan per pill/ingot. ②With the production and marketization of cultivated musk in the body, as well as the pilot project of lifting the ban on the import of natural musk in China, industry insiders expect that the tight supply and demand situation of musk raw materials will be alleviated.

cls.cnSep 23 00:55 ET

CP smart home AI health services will be launched this year. Guangxi Liuyao Group: The new online settlement policy is conducive to improving the current high accounts receivable situation. | Direct hit earnings conference

At the earnings conference, Chairman Zhu Chaoyang of Guangxi Liuyao Group introduced the progress of the company's AI scenario application business. For the high accounts receivable, the company's CFO Zeng Xiangxing stated that the company has adjusted its operational strategy and strengthened the collection efforts. Guangxi Liuyao Group also responded to the slight decline in growth of the pharmaceutical wholesale sector and issues related to the expansion of pharmaceutical new retail business.

cls.cnSep 11 08:30 ET

Traditional Chinese medicine health products face difficulties in transitioning online. Shouxiangu Pharmaceuticals: Striving to have top anchors promote products during the singles' day sales. | Earnings conference in focus.

①The demand for traditional Chinese medicine health products has not improved; ②Zhejiang Shouxiangu pharmaceutical is promoting singles' day sales through live streaming hosts; ③Multiple measures are taken to maintain product price stability; ④Online transformation still faces certain challenges.

cls.cnSep 11 08:13 ET